ALL INSIGHTS

Indication Selection

Spatial Proteomics
Patient Stratification
Oncology
Immunology
Overview

In clinical trial design, selecting the right indication for a drug or therapy is essential for ensuring that the trial targets the appropriate patient population. Indication selection is a multifaceted and complicated process which ultimately requires scientific rationale for why a certain indication is chosen.

‍

This report will offer insights into biological features that are present in patients across multiple disease indications, which may be leveraged for selecting indications for clinical trials.

Key Questions Answered
What other indications could my drug be effective for?
Which patients across the indications are likely to respond to therapy?
Outputs
  1. Quantification of cellular and spatial features, in the context of a drug target or a biomarker of therapeutic response
  2. Ranked list of patients by disease type based on presence of clinically relevant biological features
Deliverables
Insights Report
ECP Visualizer
ECP Explorer
Image(s)
Data Plot(s)
Data Table(s)
CSV File(s)